Cost-benefit of limited isolation and testing in COVID-19 mitigation

被引:17
|
作者
Eilersen, Andreas [1 ]
Sneppen, Kim [1 ]
机构
[1] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark
基金
欧洲研究理事会;
关键词
SPREAD;
D O I
10.1038/s41598-020-75640-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The international community has been put in an unprecedented situation by the COVID-19 pandemic. Creating models to describe and quantify alternative mitigation strategies becomes increasingly urgent. In this study, we propose an agent-based model of disease transmission in a society divided into closely connected families, workplaces, and social groups. This allows us to discuss mitigation strategies, including targeted quarantine measures. We find that workplace and more diffuse social contacts are roughly equally important to disease spread, and that an effective lockdown must target both. We examine the cost-benefit of replacing a lockdown with tracing and quarantining contacts of the infected. Quarantine can contribute substantially to mitigation, even if it has short duration and is done within households. When reopening society, testing and quarantining is a strategy that is much cheaper in terms of lost workdays than a long lockdown. A targeted quarantine strategy is quite efficient with only 5 days of quarantine, and its effect increases when testing is more widespread.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] ISSUES IN IMPLEMENTATION AND COST-BENEFIT OF PHARMACOGENETIC TESTING FOR DEPRESSION
    Kennedy, James L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 75 : S2 - S2
  • [32] Serostatus testing and dengue vaccine cost-benefit thresholds
    Pearson, Carl A. B.
    Abbas, Kaja M.
    Clifford, Samuel
    Flasche, Stefan
    Hladish, Thomas J.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2019, 16 (157)
  • [33] A National Strategy for COVID-19 Testing, Surveillance, and Mitigation Strategies
    Michaels, David
    Emanuel, Ezekiel J.
    Bright, Rick A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (03): : 213 - 214
  • [34] False Negative Mitigation in Group Testing for COVID-19 Screening
    Alizad-Rahvar, Amir Reza
    Vafadar, Safar
    Totonchi, Mehdi
    Sadeghi, Mehdi
    FRONTIERS IN MEDICINE, 2021, 8
  • [35] A retrospective review of COVID-19 testing and mitigation strategies at a psychiatric hospital and subsequent COVID-19 acquisition
    Klousnitzer, Jessie
    Tatar, Janina-Marie
    Snyder, Amy H.
    Snyder, Graham M.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (12) : 1360 - 1365
  • [36] COST-BENEFIT OF PATCH TESTING WITH TEXTILE FINISH RESINS
    ANDERSEN, KE
    HAMANN, K
    CONTACT DERMATITIS, 1982, 8 (01) : 64 - 67
  • [37] Guiding Covid policy: cost-benefit analysis and beyond
    Aldred, Jonathan
    CAMBRIDGE JOURNAL OF ECONOMICS, 2022, 46 (03) : 589 - 608
  • [38] The costs of COVID-19 and the cost-effectiveness of testing
    Gonzalez Lopez-Valcarcel, Beatriz
    Vallejo-Torres, Laura
    APPLIED ECONOMIC ANALYSIS, 2021, 29 (85): : 77 - 89
  • [39] Widespread smell testing for COVID-19 has limited application
    Hopkins, Claire
    Smith, Barry
    LANCET, 2020, 396 (10263): : 1630 - 1630
  • [40] Cost-Benefit Analysis of Voltage Sag Mitigation Methods in Cement Plants
    Goswami, Arup Kumar
    Gupta, Chandra Prakash
    Singh, Girish Kumar
    2014 IEEE 16TH INTERNATIONAL CONFERENCE ON HARMONICS AND QUALITY OF POWER (ICHQP), 2014, : 866 - 870